Developer docs
API playgroundTry for free, no card

Search company profiles

Excelra

Full company profile

uuid00038nb

Namestring
Excelra
Legal namestring
Excelra Knowledge Solution Pvt Ltd
Websiteurl
excelra.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Excelra (legal entity Excelra Knowledge Solution Pvt Ltd) is a Hyderabad-headquartered, privately held life sciences informatics company founded in 2016, with offices in the US, UK, Belgium, and the Netherlands, and a headcount of 501-1,000 including 1,000+ domain experts. It serves 16 of the top 20 pharmaceutical companies and 135+ global partners, delivering a portfolio built around its GOSTAR™ family of manually curated Structure-Activity Relationship databases (10.6M+ molecules, 35M+ SAR data points, 79K+ targets), augmented by GOSTAR™ TPD and GOSTAR™ Large Molecules for emerging therapeutic modalities.

The technology stack combines data, platforms, and AI. Beyond databases, Excelra operates BioVisualizer™ for biological data visualization, the OP² no-code NGS pipeline platform, an Excelra Cloud Solution for scalable compute, and an AI Lab comprising CelraAI (agentic literature intelligence), PubAI (semantic knowledge graphs), RegAI (regulatory RAG), and LiftFlowAI (workflow orchestration). It complements these platforms with professional services across bioinformatics, computational biology, cheminformatics, data curation, semantics/knowledge graphs, FAIRification, HEOR-RWE, lab informatics implementation, and cloud enablement.

Excelra monetizes through GOSTAR™ subscription licensing (annual, enterprise), fee-for-service bioinformatics and scientific informatics engagements, and usage-based SaaS for OP². GTM is primarily direct enterprise field sales to large pharma and biotech, supported by integrations with nine major ELN/LIMS vendors (IDBS, Sapio, Dotmatics, Benchling, STARLIMS, Biovia, Labvantage, Thermo Fisher, Revvity) and a self-service tier for OP². Recent inorganic moves — the BISC Global acquisition and strategic investment in Anlitiks — extend capability into European bioinformatics delivery and HEOR/RWE analytics respectively.

Short descriptiontext

Excelra is a privately held, India-headquartered life sciences informatics company that combines the GOSTAR™ curated SAR databases, AI-driven platforms (CelraAI, PubAI, RegAI, LiftFlowAI), and bioinformatics/professional services to serve 16 of the top 20 pharmaceutical companies and 135+ global partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersIselin, United States
HQ citystring
Iselin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life sciences informatics, SAR database solutions, bioinformatics services, drug discovery analytics, pharmaceutical data science
Industry5 codes
PRIMARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code4 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
  • Computer Systems Design and Related Services54151
  • Other Scientific and Technical Consulting Services54169
SIC code2 codes
  • Services-Computer Programming, Data Processing, Etc.7370
  • Services-Computer Processing & Data Preparation7374
Product category
Life Sciences Informatics and Data Analytics
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1GOSTAR™ Database Licensing
TypeSubscription Recurring
Description

Subscription-based licensing of SAR databases (Small Molecules, TPD, Large Molecules) with options for bulk download, API access, and custom curation. Customers can access via graphical interface, flat files, or web API.

excelra.com
2Bioinformatics Services
TypeProfessional Services
Description

Fee-for-service bioinformatics, computational biology, and data science consulting including multi-omics analysis, biomarker discovery, target identification, and AI/ML solutions.

excelra.com
3Scientific Informatics Services
TypeProfessional Services
Description

Scientific application development, data management, lab informatics (ELN/LIMS), and cloud enablement services for enterprise clients.

excelra.com
4HEOR & RWE Services
TypeProfessional Services
Description

Health Economics and Outcomes Research services including outcomes research, epidemiology modeling, economic modeling, value evidence communication, and real-world evidence analytics.

excelra.com
5OP² Platform Subscription
TypeSubscription Recurring
Description

SaaS platform for NGS bioinformatics pipelines with tiered access: Try (free), Trial (free limited), and Full Access (usage-based pricing per sample processed).

excelra.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Pricing details4 tiers
1OP² Try - Free tier with limited access
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free instant access with example datasets, limited to 2 samples with example data only, no commitment required.

excelra.com
2OP² Trial - Free trial with own data
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free trial to explore own research data using advanced pipelines with personalized onboarding support. Limited to 2 samples by default.

excelra.com
3OP² Full Access - Pay-per-sample
ModelUsage-basedBilling cadenceMonthly
Notes

Full platform access without limitations. Transparent pricing: only pay for analyses run. Includes flexible monthly budget controls and priority technical support.

excelra.com
4GOSTAR™ Database - Enterprise licensing
ModelSubscriptionBilling cadenceAnnual
Notes

Custom pricing based on organization size and access requirements. Options include graphical interface, bulk download, API access, and custom curation with <48 hour turnaround.

excelra.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Excelra provides data science and informatics solutions for life sciences R&D, centered on the GOSTAR™ family of manually curated SAR databases (small molecules, targeted protein degraders, large molecules) and an AI Lab platform comprising CelraAI, PubAI, RegAI, and LiftFlowAI. The company also delivers bioinformatics, cheminformatics, computational biology, data curation, semantic/knowledge graph, HEOR-RWE, and scientific informatics services, alongside platforms such as BioVisualizer™, OP², and Excelra Cloud Solution. Offerings are targeted at pharmaceutical, biotech, agrigenomics, diagnostics, and animal health organizations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 30-40% reduction in review time for mRNA research workflows
+6 more records
Product overview1 text field

Excelra is a data science and informatics company offering a unified portfolio of databases, platforms, and services for life sciences R&D. The core product is the GOSTAR™ family of SAR databases, including GOSTAR™ Small Molecules (10.6M+ compounds), GOSTAR™ TPD (45K+ protein degraders), and GOSTAR™ Large Molecules (custom curated for antibodies, oligonucleotides, peptides). The technology platform includes BioVisualizer™ for data visualization, OP² (Online Pipeline Platform) for NGS analysis, Excelra Cloud Solution for cloud computing, and AI Lab featuring CelraAI, PubAI, RegAI, and LiftFlowAI for AI-powered discovery. Scientific services span bioinformatics, computational biology, cheminformatics, data curation, semantics, FAIRification, visualization, HEOR-RWE, scientific informatics, application development, data management, lab informatics, and cloud enablement. Founded in 2016 with 1000+ domain experts and partnerships with 16 of the top 20 pharmaceutical companies.

Product and service1 record
1GOSTAR™ Small Molecules
Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1BISC Global
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Acquisition creating an international bioinformatics powerhouse with industry-leading platform and service offering. Combines BISC Global's expertise with Excelra's existing capabilities.

excelra.com
Strategic tierCoreTypeTechnology or Integration
Description

IDBS partner ecosystem collaboration providing enhanced lab informatics solutions. IDBS is known for E-WorkBook product and BioPharma Lifecycle Management solutions across 18 of top 20 global BioPharma companies.

3Sapio Sciences
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership to enhance lab informatics solutions with comprehensive and streamlined laboratory workflow management combining Sapio's all-in-one science-aware platform with Excelra's domain expertise.

excelra.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic investment in disruptive HEOR and RWE technology-led consulting company. Reinforces Excelra's push into Health Economics and Outcomes Research analytics by combining scientific domain expertise with cutting-edge technology.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Biovia provides scientific informatics solutions including ELN, LIMS, and molecular modeling tools as part of the broader Dassault Systèmes 3DEXPERIENCE platform. It competes with Excelra's lab informatics and scientific data management services at large enterprise accounts.

TypeBroad incumbent
Description

Clarivate is a large public provider of life sciences and intellectual property data and analytics (including Cortellis, Derwent). It competes with Excelra in curated scientific data and analytics for pharma R&D and commercialization, with a much broader portfolio.

3Elsevier (Reaxys)
TypeBroad incumbent
Description

Elsevier operates Reaxys and Embase, major chemistry and biomedical databases with curated SAR and literature content. Reaxys is the most direct competitor to GOSTAR in the curated SAR database market for pharma R&D.

TypeDirect peer
Description

Dotmatics provides a scientific R&D platform spanning ELN, LIMS, biology, and chemistry informatics, and is one of the most direct competitors to Excelra's lab informatics and data management offerings. Like Excelra, it targets large pharma and biotech R&D organizations.

TypeDirect peer
Description

Benchling is a cloud-native R&D platform for biology, including ELN, registries, and workflow tools, widely used by biotech and pharma. It competes with Excelra's scientific informatics and lab informatics offerings for the same enterprise customer base.

TypeDirect peer
Description

Schrödinger provides computational chemistry and predictive informatics software for drug discovery, including the LiveDesign platform. It overlaps with Excelra's cheminformatics, computational biology, and AI-driven drug discovery capabilities.

TypeDirect peer
Description

LabVantage is a dedicated LIMS provider serving pharmaceutical, biotech, and other regulated industries. It is both a partner and competitor in the lab informatics segment where Excelra delivers ELN/LIMS implementation and managed services.

8Sapio Sciences
TypeDirect peer
Description

Sapio offers an all-in-one science-aware LIMS, ELN, and Jarvis data platform for biopharma, CRO/CDMOs, and clinical diagnostic labs. It competes head-to-head with Excelra's lab informatics services and is also a strategic integration partner.

TypeDirect peer
Description

IDBS provides the E-WorkBook ELN and BioPharma Lifecycle Management (BPLM) platform, serving 18 of the top 20 global biopharma companies. It is both a partner and a direct competitor to Excelra's lab informatics and scientific data management services.

10Chemical Abstracts Service (CAS)
TypeBroad incumbent
Description

CAS, a division of the American Chemical Society, provides the CAS Registry and related chemistry data and analytics services. It is a long-established competitor in the curated scientific chemistry and life sciences data space where GOSTAR operates.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration14 records

Each record includes

Title, Type, Description, Source

AI capability12 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Excelra

Life Sciences Informatics and Data Analyticsexcelra.com

Excelra is a privately held, India-headquartered life sciences informatics company that combines the GOSTAR™ curated SAR databases, AI-driven platforms (CelraAI, PubAI, RegAI, LiftFlowAI), and bioinformatics/professional services to serve 16 of the top 20 pharmaceutical companies and 135+ global partners.

What Excelra does

Excelra (legal entity Excelra Knowledge Solution Pvt Ltd) is a Hyderabad-headquartered, privately held life sciences informatics company founded in 2016, with offices in the US, UK, Belgium, and the Netherlands, and a headcount of 501-1,000 including 1,000+ domain experts. It serves 16 of the top 20 pharmaceutical companies and 135+ global partners, delivering a portfolio built around its GOSTAR™ family of manually curated Structure-Activity Relationship databases (10.6M+ molecules, 35M+ SAR data points, 79K+ targets), augmented by GOSTAR™ TPD and GOSTAR™ Large Molecules for emerging therapeutic modalities.

The technology stack combines data, platforms, and AI. Beyond databases, Excelra operates BioVisualizer™ for biological data visualization, the OP² no-code NGS pipeline platform, an Excelra Cloud Solution for scalable compute, and an AI Lab comprising CelraAI (agentic literature intelligence), PubAI (semantic knowledge graphs), RegAI (regulatory RAG), and LiftFlowAI (workflow orchestration). It complements these platforms with professional services across bioinformatics, computational biology, cheminformatics, data curation, semantics/knowledge graphs, FAIRification, HEOR-RWE, lab informatics implementation, and cloud enablement.

Excelra monetizes through GOSTAR™ subscription licensing (annual, enterprise), fee-for-service bioinformatics and scientific informatics engagements, and usage-based SaaS for OP². GTM is primarily direct enterprise field sales to large pharma and biotech, supported by integrations with nine major ELN/LIMS vendors (IDBS, Sapio, Dotmatics, Benchling, STARLIMS, Biovia, Labvantage, Thermo Fisher, Revvity) and a self-service tier for OP². Recent inorganic moves — the BISC Global acquisition and strategic investment in Anlitiks — extend capability into European bioinformatics delivery and HEOR/RWE analytics respectively.

Excelra firmographics

Firmographics
Name
Excelra
Legal name
Excelra Knowledge Solution Pvt Ltd
Website
https://excelra.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Excelra is a privately held, India-headquartered life sciences informatics company that combines the GOSTAR™ curated SAR databases, AI-driven platforms (CelraAI, PubAI, RegAI, LiftFlowAI), and bioinformatics/professional services to serve 16 of the top 20 pharmaceutical companies and 135+ global partners.
Ownership category
akta.pro rank

Excelra industry classification

Industry
Product category
Life Sciences Informatics and Data Analytics
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Computer Systems Design and Related Services (54151), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Computer Programming, Data Processing, Etc. (7370), Services-Computer Processing & Data Preparation (7374)
akta.pro industry
PRIMARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Life sciences informatics
  • SAR database solutions
  • Bioinformatics services
  • Drug discovery analytics
  • Pharmaceutical data science

Where Excelra is headquartered

Location

Headquarters

HQ city
Iselin
HQ country
United States
HQ region
North America

Offices6 records

Markets served

Excelra business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. GOSTAR™ Database Licensing: Subscription-based licensing of SAR databases (Small Molecules, TPD, Large Molecules) with options for bulk download, API access, and custom curation. Customers can access via graphical interface, flat files, or web API.
  2. Bioinformatics Services: Fee-for-service bioinformatics, computational biology, and data science consulting including multi-omics analysis, biomarker discovery, target identification, and AI/ML solutions.
  3. Scientific Informatics Services: Scientific application development, data management, lab informatics (ELN/LIMS), and cloud enablement services for enterprise clients.
  4. HEOR & RWE Services: Health Economics and Outcomes Research services including outcomes research, epidemiology modeling, economic modeling, value evidence communication, and real-world evidence analytics.
  5. OP² Platform Subscription: SaaS platform for NGS bioinformatics pipelines with tiered access: Try (free), Trial (free limited), and Full Access (usage-based pricing per sample processed).

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goOP² Try - Free tier with limited access
FreemiumPay-as-you-goOP² Trial - Free trial with own data
Usage-basedMonthlyOP² Full Access - Pay-per-sample
SubscriptionAnnualGOSTAR™ Database - Enterprise licensing

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Excelra product offering

Product offering

Core offering

Excelra provides data science and informatics solutions for life sciences R&D, centered on the GOSTAR™ family of manually curated SAR databases (small molecules, targeted protein degraders, large molecules) and an AI Lab platform comprising CelraAI, PubAI, RegAI, and LiftFlowAI. The company also delivers bioinformatics, cheminformatics, computational biology, data curation, semantic/knowledge graph, HEOR-RWE, and scientific informatics services, alongside platforms such as BioVisualizer™, OP², and Excelra Cloud Solution. Offerings are targeted at pharmaceutical, biotech, agrigenomics, diagnostics, and animal health organizations.

Product overview

Excelra is a data science and informatics company offering a unified portfolio of databases, platforms, and services for life sciences R&D. The core product is the GOSTAR™ family of SAR databases, including GOSTAR™ Small Molecules (10.6M+ compounds), GOSTAR™ TPD (45K+ protein degraders), and GOSTAR™ Large Molecules (custom curated for antibodies, oligonucleotides, peptides). The technology platform includes BioVisualizer™ for data visualization, OP² (Online Pipeline Platform) for NGS analysis, Excelra Cloud Solution for cloud computing, and AI Lab featuring CelraAI, PubAI, RegAI, and LiftFlowAI for AI-powered discovery. Scientific services span bioinformatics, computational biology, cheminformatics, data curation, semantics, FAIRification, visualization, HEOR-RWE, scientific informatics, application development, data management, lab informatics, and cloud enablement. Founded in 2016 with 1000+ domain experts and partnerships with 16 of the top 20 pharmaceutical companies.

Differentiator

Problem solved

Functional benefit

Products and services

  • GOSTAR™ Small Molecules

Quantifiable outcome

  • 30-40% reduction in review time for mRNA research workflows
  • +6 more outcomes

Companies that use Excelra

Customer profile

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Excelra technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration14 records

AI capability12 records

Feature11 records

Excelra partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • BISC GlobalcoreStrategic or Co-development PartnerAcquisition creating an international bioinformatics powerhouse with industry-leading platform and service offering. Combines BISC Global's expertise with Excelra's existing capabilities.
  • IDBScoreTechnology or IntegrationIDBS partner ecosystem collaboration providing enhanced lab informatics solutions. IDBS is known for E-WorkBook product and BioPharma Lifecycle Management solutions across 18 of top 20 global BioPharma companies.
  • Sapio SciencescoreStrategic or Co-development PartnerStrategic partnership to enhance lab informatics solutions with comprehensive and streamlined laboratory workflow management combining Sapio's all-in-one science-aware platform with Excelra's domain expertise.
  • AnlitikscoreStrategic or Co-development PartnerStrategic investment in disruptive HEOR and RWE technology-led consulting company. Reinforces Excelra's push into Health Economics and Outcomes Research analytics by combining scientific domain expertise with cutting-edge technology.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Excelra competitors and assessment

Company assessment

Broad incumbents

  • Biovia (Dassault Systèmes): Biovia provides scientific informatics solutions including ELN, LIMS, and molecular modeling tools as part of the broader Dassault Systèmes 3DEXPERIENCE platform. It competes with Excelra's lab informatics and scientific data management services at large enterprise accounts.
  • Clarivate: Clarivate is a large public provider of life sciences and intellectual property data and analytics (including Cortellis, Derwent). It competes with Excelra in curated scientific data and analytics for pharma R&D and commercialization, with a much broader portfolio.
  • Elsevier (Reaxys): Elsevier operates Reaxys and Embase, major chemistry and biomedical databases with curated SAR and literature content. Reaxys is the most direct competitor to GOSTAR in the curated SAR database market for pharma R&D.
  • Chemical Abstracts Service (CAS): CAS, a division of the American Chemical Society, provides the CAS Registry and related chemistry data and analytics services. It is a long-established competitor in the curated scientific chemistry and life sciences data space where GOSTAR operates.

Direct peers

  • Dotmatics: Dotmatics provides a scientific R&D platform spanning ELN, LIMS, biology, and chemistry informatics, and is one of the most direct competitors to Excelra's lab informatics and data management offerings. Like Excelra, it targets large pharma and biotech R&D organizations.
  • Benchling: Benchling is a cloud-native R&D platform for biology, including ELN, registries, and workflow tools, widely used by biotech and pharma. It competes with Excelra's scientific informatics and lab informatics offerings for the same enterprise customer base.
  • Schrödinger: Schrödinger provides computational chemistry and predictive informatics software for drug discovery, including the LiveDesign platform. It overlaps with Excelra's cheminformatics, computational biology, and AI-driven drug discovery capabilities.
  • LabVantage Solutions: LabVantage is a dedicated LIMS provider serving pharmaceutical, biotech, and other regulated industries. It is both a partner and competitor in the lab informatics segment where Excelra delivers ELN/LIMS implementation and managed services.
  • Sapio Sciences: Sapio offers an all-in-one science-aware LIMS, ELN, and Jarvis data platform for biopharma, CRO/CDMOs, and clinical diagnostic labs. It competes head-to-head with Excelra's lab informatics services and is also a strategic integration partner.
  • IDBS (Danaher): IDBS provides the E-WorkBook ELN and BioPharma Lifecycle Management (BPLM) platform, serving 18 of the top 20 global biopharma companies. It is both a partner and a direct competitor to Excelra's lab informatics and scientific data management services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Excelra social profiles

Digital presence

Excelra compliance and trust

Trust signal

Compliance1 record

Excelra financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Excelra leadership team

Management profile

Number of profiles

Profiles8 records

Excelra subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Excelra funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Excelra M&A and investment

M&A and investment

M&A2 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Excelra

What does Excelra do?

Excelra provides data science and informatics solutions for life sciences R&D, centered on the GOSTAR™ family of manually curated SAR databases (small molecules, targeted protein degraders, large molecules) and an AI Lab platform comprising CelraAI, PubAI, RegAI, and LiftFlowAI. The company also delivers bioinformatics, cheminformatics, computational biology, data curation, semantic/knowledge graph, HEOR-RWE, and scientific informatics services, alongside platforms such as BioVisualizer™, OP², and Excelra Cloud Solution. Offerings are targeted at pharmaceutical, biotech, agrigenomics, diagnostics, and animal health organizations.

Is Excelra a public or private company?

Excelra is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Excelra founded?

Excelra was founded in 2016. It employs 1,001 to 5,000 people.

Where is Excelra based?

Excelra is headquartered in Iselin, United States, in the North America region.

How does Excelra make money?

Five revenue lines are on record. GOSTAR™ Database Licensing is the primary driver. The others are bioinformatics Services, scientific Informatics Services, HEOR & RWE Services and OP² Platform Subscription.

Who are Excelra's main competitors?

Broad incumbents on record are Biovia (Dassault Systèmes), Clarivate, Elsevier (Reaxys) and Chemical Abstracts Service (CAS). Direct peers are Dotmatics, Benchling, Schrödinger, LabVantage Solutions, Sapio Sciences and IDBS (Danaher).

Does Excelra have an API?

Yes. GOSTAR™ databases offer flexible data access options including a web API. Data can be pulled from GOSTAR™ databases using an API, enabling programmatic access to 35 million rows of SAR data across small molecules and TPD databases. Data available in formats including flat files, hierarchical files, semantic format, Oracle databases, MySQL™ databases, or via web API. Custom curation services available with rapid turnaround.

What industry is Excelra in?

Excelra's product category is Life Sciences Informatics and Data Analytics. Its primary akta.pro industry code is HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D), with a secondary code of HLAGAJAD, Bioinformatics & Multi-omics Analysis Software. Its NAICS code is 541714 and its SIC code is 7370.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The TribuneExcelras GOSTAR™ Powers Boltzs AI Models for Drug Discovery - The TribuneBoltz PBC partnered with Excelra to power its BoltzMol-1 AI drug discovery models with GOSTAR data, which trains ADMET models. The models filtered out unfavorable compounds before synthesis, and prospective testing of ten targets yielded binders for six using 28–96 compounds each. The GOSTAR-trained models matched or exceeded open-source ADMET packages on out-of-distribution chemistry.Business StandardExcelra's GOSTAR™ Powers Boltz's AI Models for Drug DiscoveryBoltz PBC partnered with Excelra to use GOSTAR data for its ADMET models, testing ten targets and confirming binders for six with 28-96 compounds each. The GOSTAR-trained models matched or exceeded open-source ADMET packages on out-of-distribution chemistry, with gains in solubility and permeability.PRESSBEEExcelras GOSTAR™ unterstützt KI-Modelle von Boltz für die Wirkstoffforschung ...Middle EastBoltz PBC and Excelra announced a partnership to use Excelra's GOSTAR curated ADME data to train Boltz's AI-based ADMET models for drug discovery. The collaboration aims to support AI-driven drug research, with the announcement made on PR Newswire.AktienExcelras GOSTAR unterstützt KI-Modelle von Boltz für die WirkstoffforschungBoltz PBC partnered with Excelra to train its ADMET models on curated GOSTAR data, using kinetic solubility, lipophilicity, and Caco-2 permeability. The models outperformed open-source ADMET packages on out-of-distribution chemistry, and Boltz prospectively identified binders for six of ten targets using 28–96 compounds each.PR NewswireExcelras GOSTAR™ unterstützt KI-Modelle von Boltz für die WirkstoffforschungBoltz PBC partnered with Excelra to train its ADMET models on Excelra's GOSTAR data, using curated measurements of solubility, lipophilicity, and Caco-2 permeability. The models outperformed open-source ADMET packages on out-of-distribution chemistry, and Boltz prospectively validated binders for six of ten targets using 28–96 compounds per target.Indian Economic ObserverExcelra's GOSTAR™ Powers Boltz's AI Models for Drug DiscoveryBoltz PBC partnered with Excelra to power its AI drug discovery models with GOSTAR data, using curated measurements of kinetic solubility, lipophilicity, and Caco-2 permeability. The company tested ten challenging targets and confirmed binders for six using 28–96 compounds per target, versus thousands in conventional screens.The TribuneExcelras GOSTAR™ Powers Boltzs AI Models for Drug Discovery - The TribuneBoltz PBC partnered with Excelra to power its AI drug discovery models with GOSTAR data, using curated measurements of kinetic solubility, lipophilicity, and Caco-2 permeability. The company tested ten challenging targets and confirmed binders for six using 28–96 compounds per target, versus thousands in conventional screens.Ani NewsExcelra's GOSTAR™ Powers Boltz's AI Models for Drug DiscoveryBoltz PBC partnered with Excelra to use GOSTAR data for its ADMET models, filtering compounds before synthesis. The models matched or exceeded open-source ADMET packages on out-of-distribution chemistry, and prospective testing of ten targets yielded binders for six using 28–96 compounds each.PR NewswireExcelra's GOSTAR™ Powers Boltz's AI Models for Drug DiscoveryBoltz PBC partnered with Excelra to use GOSTAR data for its BoltzMol-1 ADMET models, which filter compounds before synthesis. The models matched or exceeded open-source ADMET packages on out-of-distribution chemistry, and Boltz tested ten targets, finding binders for six with 28–96 compounds each.PR Newswire APACExcelra's GOSTAR™ Powers Boltz's AI Models for Drug DiscoveryBoltz PBC partnered with Excelra to use GOSTAR data for its BoltzMol-1 ADMET models, which filter compounds before synthesis. The models matched or exceeded open-source ADMET packages on out-of-distribution chemistry, and prospectively identified binders for six of ten targets using 28–96 compounds each.